Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

J Dermatolog Treat. 2023 Dec;34(1):2268764. doi: 10.1080/09546634.2023.2268764. Epub 2023 Oct 11.NO ABSTRACTPMID:37818648 | DOI:10.1080/09546634.2023.2268764
Source: Journal of Dermatological Treatment - Category: Dermatology Authors: Source Type: research